Atavistik Bio is a privately-held clinical stage biotechnology company accelerating the discovery and development of transformative precision allosteric therapeutics to address serious unmet patient needs. Our proprietary AMPS™ platform allows us to rapidly unlock functional cryptic pockets across a broad range of target classes to accelerate the development of groundbreaking medicines. We have rapidly established an emerging pipeline of allosteric therapeutics with the potential to achieve superior efficacy and tolerability profiles by leveraging the power of allostery. Atavistik Bio is led by an experienced team of drug hunters with a proven track record of developing marketed small molecule therapies and supported by top-tier investors, including The Column Group, Nextech Invest, Lux Capital, Regeneron Ventures, and RA Capital Management. We are seeking a strategic and dynamic Scientist II/Senior Scientist with deep expertise in probing GPCR signaling in cell and animal models, to join our R&D group and work with an enthusiastic team of highly skilled scientists in a fast-paced environment. Reporting to the SVP, Head of Biology, this individual will be responsible for leading screening campaigns for small molecule drug candidates. The ideal candidate will have extensive experience in developing cell-based assays to measure multiple GPCR-dependent read-outs, high-throughput screening, and the ability to work cross-functionally in a dynamic environment. This position is primarily lab-based, and will also involve CRO-management.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior
Education Level
Ph.D. or professional degree